Prot# EN3348-303: A Phase 3, Randomized, Active-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348(MCC) as Compared with Mitomycin C in the Intravesical Treatment of Subjects wit BCG Recurrent or Refractory Non-Muscle

Project: Research project

StatusFinished
Effective start/end date2/2/122/2/15

Funding

  • Clinical Financial Services, LLC (EN3348-303)
  • Endo Pharmaceuticals Inc (EN3348-303)